30 results
8-K
EX-99.1
BTAX
Biostax Corp.
14 Nov 23
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
4:22pm
Secretary of Health and Human Resources under the office of Secretary Jane Woods where he exhibited exceptional leadership in policy coordination … empowerment, Craig Suro continues to shape Virginia’s future. His dynamic approach and visionary leadership make him a driving force behind transformative
8-K
EX-99.1
BTAX
Biostax Corp.
14 Sep 23
Biostax Corp Announces the Passing of Esteemed Director, Henry Louis Salomonsky
9:00am
a wealth of knowledge, experience, and leadership.
Biostax expresses its deepest condolences to Mr. Salomonksy’s family during this difficult time. His
PRE 14C
BTAX
Biostax Corp.
16 Dec 22
Preliminary information
4:31pm
leadership and his previous board memberships.
Glen Farmer. Mr. Farmer was appointed as the Chief Executive Officer on August 2022. From April 2018
8-K
EX-99.1
BTAX
Biostax Corp.
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
Board of Directors.
“On behalf of the Board and leadership of Immune, I would like to welcome Louis to Immune’s Board,” said Dr. Stephen Wilson, CEO … of Immune. “Mr. Salomonsky’s operational leadership, as well as his track record of deal-making and financial acumen, will be instrumental in moving
8-K
d9vu0q10 pc
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
8-K
EX-99.1
sxgx004zud
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
euy1dsz
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
df3o40r
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
EX-99.1
vcn5bzqngq ns1dwp1
22 Oct 20
Immune Therapeutics, Inc. Announces Signing of Definitive Merger Agreement Between Cytocom and Cleveland BioLabs
4:33pm
8-K
dl5qdn
5 May 20
Departure of Directors or Certain Officers
5:19pm
8-K
fk126
14 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
e8gu0thhadou zfupyd
14 Jan 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
ky59mdq 809mruodp3y8
4 Dec 14
Other Events
12:00am
10-K
vl9ii
31 Mar 14
Annual report
12:00am
10-12G/A
k26ylp3o2 71
7 Feb 14
Registration of securities (amended)
12:00am